Non-small cell lung cancer

You have access
ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent
TAMIO OKIMOTO, YUKARI TSUBATA, RYOSUKE TANINO, MIKA NAKAO, TAKAMASA HOTTA, MEGUMI HAMAGUCHI, SHUNICHI HAMAGUCHI, ASUKA ARAKI and TAKESHI ISOBE

Anticancer Research May 2021, 41 (5) 2653-2660; DOI: https://doi.org/10.21873/anticanres.15046
You have access
Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer
MAY MYAT MON, CHANTRAGAN SRISOMSAP, DARANEE CHOKCHAICHAMNANKIT, KAMOLWAN WATCHARATANYATIP, CHURAT WEERAPHAN, JISNUSON SVASTI, KAJORNKIAT MANEECHAI, PARAMEE THONGSUKSAI and PRITSANA RAUNGRUT

Anticancer Research April 2021, 41 (4) 1871-1882; DOI: https://doi.org/10.21873/anticanres.14953
You have access
Impact of Renin–angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
TAKEHIRO TOZUKA, NORIKO YANAGITANI, HIROSHI YOSHIDA, RYO MANABE, SHINSUKE OGUSU, RYOSUKE TSUGITOMI, HIROAKI SAKAMOTO, YOSHIAKI AMINO, RYO ARIYASU, KEN UCHIBORI, SATORU KITAZONO, MASAHIRO SEIKE, AKIHIKO GEMMA and MAKOTO NISHIO

Anticancer Research April 2021, 41 (4) 2093-2100; DOI: https://doi.org/10.21873/anticanres.14980
You have access
Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells
WEI-TING CHEN, CHENG-HSIEN CHEN, HUNG-TAI SU, PO-FU YUEH, FEI-TING HSU and I-TSANG CHIANG

Anticancer Research March 2021, 41 (3) 1357-1364; DOI: https://doi.org/10.21873/anticanres.14893
You have access
Complete Response of Bone Metastasis in Non-small Cell Lung Cancer With Pembrolizumab: Two Case Reports
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOSHIHIRO ARAKI, SEI MORINAGA, KAZUO KASAHARA, TAKASHI SONE and HIROYUKI TSUCHIYA

Anticancer Research March 2021, 41 (3) 1693-1699; DOI: https://doi.org/10.21873/anticanres.14933
You have access
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS

Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
You have access
Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer
YU-CHANG LIU, BO-HAN HUANG, JING-GUNG CHUNG, WEI-LIN LIU, FEI-TING HSU and SONG-SHEI LIN

Anticancer Research January 2021, 41 (1) 123-130; DOI: https://doi.org/10.21873/anticanres.14757
You have access
Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
CARSTEN NIEDER, KRISTIAN S. IMINGEN, BARD MANNSAKER and ROSALBA YOBUTA

Anticancer Research January 2021, 41 (1) 355-358; DOI: https://doi.org/10.21873/anticanres.14783
You have access
Activation of Toll-Like Receptor 2 Promotes Proliferation of Human Lung Adenocarcinoma Cells
ANNA K. GERGEN, PATRICK D. KOHTZ, ALISON L. HALPERN, ANQI LI, XIANZHONG MENG, T. BRETT REECE, DAVID A. FULLERTON and MICHAEL J. WEYANT

Anticancer Research October 2020, 40 (10) 5361-5369; DOI: https://doi.org/10.21873/anticanres.14544
You have access
A Novel System to Detect Circulating Tumor Cells Using Two Different Size-selective Microfilters
TOMOAKI SONODA, NORIKO YANAGITANI, KANAKO SUGA, TAKAHIRO YOSHIZAWA, SHINGO NISHIKAWA, SATORU KITAZONO, ATSUSHI HORIIKE, KIYOTAKA SHIBA, TAMOTSU ISHIZUKA, MAKOTO NISHIO and SATOSHI MATSUSAKA

Anticancer Research October 2020, 40 (10) 5577-5582; DOI: https://doi.org/10.21873/anticanres.14570

Main menu

User menu

Search

Non-small cell lung cancer

Pages